Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-12-01 | 2025-09-23 |
| Drug Identification Number | 02244931 | 02244931 |
| Brand name | MESNA FOR INJECTION | MESNA FOR INJECTION |
| Common or Proper name | Mesna for Injection 100 mg/mL 10 mL vial | Mesna for Injection 100 mg/mL 10 mL vial |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | MESNA | MESNA |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL | 10 mL |
| ATC code | V03AF | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2025-10-01 | 2025-10-01 |
| Actual start date | 2025-10-01 | |
| Estimated end date | 2025-11-30 | 2025-10-31 |
| Actual end date | 2025-12-02 | |
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi regrets to advice that due to a production delay, we will be encountering a supply interruption in this product, expected from October 1st to November 30, 2025. | Fresenius Kabi regrets to advice that due to a production delay, we will be encountering a supply interruption in this product, expected from October 1st to November 30, 2025. |
| Health Canada comments |